| 9902 | A | 065339 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | EBEWE PHARMA | 50MG/25ML (2MG/ML) | | [] | 2009-12-22 | Dec 22, 2009 | No | No | No | DISCN | EBEWE PHARMA GES MBH NFG KG | c933da51199a87a89e5aa7b429c3bcda724ad4b8a662c3139f7e5cf43613eb15 |
| 9903 | A | 065339 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | EBEWE PHARMA | 200MG/100ML (2MG/ML) | | [] | 2009-12-22 | Dec 22, 2009 | No | No | No | DISCN | EBEWE PHARMA GES MBH NFG KG | 9e7594c7fe09f15fb5ea74f1ff08945cb4a990898e3569d73f0f30758fe86134 |
| 9904 | A | 065408 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | FRESENIUS KABI USA | 10MG/5ML (2MG/ML) | | [] | 2007-10-15 | Oct 15, 2007 | No | No | No | RX | FRESENIUS KABI USA LLC | 072c76e5293b7e52ccef33ffb4fe089638c9e3eee18108f2e0fbe28ff1b87a0c |
| 9905 | A | 065408 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | FRESENIUS KABI USA | 50MG/25ML (2MG/ML) | AP | ["AP"] | 2007-10-15 | Oct 15, 2007 | No | No | No | RX | FRESENIUS KABI USA LLC | 01b8c148bee020c76e0d093eec012add177add85f6b872d226e04e3305913f0a |
| 9906 | A | 065408 | 003 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | FRESENIUS KABI USA | 150MG/75ML (2MG/ML) | | [] | 2007-10-15 | Oct 15, 2007 | No | No | No | RX | FRESENIUS KABI USA LLC | e20bd4d2d023865225b0c976cf96923c27be6663629b1466bac30a9709def571 |
| 9907 | A | 065408 | 004 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | FRESENIUS KABI USA | 200MG/100ML (2MG/ML) | AP | ["AP"] | 2007-10-15 | Oct 15, 2007 | No | No | No | RX | FRESENIUS KABI USA LLC | 3b1216e1ecf461c2488df458a96f4749dc55d0b7e9305a075d0f5cdc02617490 |
| 9908 | A | 065411 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | FRESENIUS KABI USA | 200MG/100ML (2MG/ML) | | [] | 2007-08-20 | Aug 20, 2007 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 96dbcf7f177f420690d86b884ce18ed102abd14fc86307c5375fd224a9fb6812 |
| 9909 | A | 065411 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | FRESENIUS KABI USA | 50MG/25ML (2MG/ML) | | [] | 2007-08-20 | Aug 20, 2007 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 4e079f0ee465adbb2997a145596a729c9a2d6e711453beedbc97e787a30224fa |
| 9910 | A | 090075 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | HISUN PHARM HANGZHOU | 50MG/25ML (2MG/ML) | AP | ["AP"] | 2010-03-25 | Mar 25, 2010 | No | No | No | RX | HISUN PHARMACEUTICAL (HANGZHOU) CO LTD | d66b603bc242640e4437b1762d8f323346b3ce56825870504b7078c31bc4bfb5 |
| 9911 | A | 090075 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | HISUN PHARM HANGZHOU | 200MG/100ML (2MG/ML) | AP | ["AP"] | 2010-03-25 | Mar 25, 2010 | No | No | No | RX | HISUN PHARMACEUTICAL (HANGZHOU) CO LTD | c71c9a04112f3a1e8d1bdd59d02df655f11198792dec3b6f1ea9b058dce9913d |
| 9912 | A | 065343 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | HOSPIRA | 10MG/5ML (2MG/ML) | | [] | 2007-04-19 | Apr 19, 2007 | No | No | No | DISCN | HOSPIRA INC | f40fb54fc50760a779660e1e616787fd7457b687a73c44f85b994a6feed47d08 |
| 9913 | A | 065343 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | HOSPIRA | 50MG/25ML (2MG/ML) | | [] | 2007-04-19 | Apr 19, 2007 | No | No | No | DISCN | HOSPIRA INC | c31a695bf22f4d5226b03ade8b33dbf5e83bc9cdcf64de845fbdc221cbd397a8 |
| 9914 | A | 065343 | 003 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | HOSPIRA | 150MG/75ML (2MG/ML) | | [] | 2007-04-19 | Apr 19, 2007 | No | No | No | DISCN | HOSPIRA INC | 7eb0bc03ccbb127f5578583bf27bffb7d551cfb34a0e0e76f4f1f4f1adb60ff9 |
| 9915 | A | 065343 | 004 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | HOSPIRA | 200MG/100ML (2MG/ML) | | [] | 2007-04-19 | Apr 19, 2007 | No | No | No | DISCN | HOSPIRA INC | 4ed77a96306649c081d97f4dc33e21b83e1b6df51e22c931034a53a28c9790b7 |
| 9916 | A | 065331 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | IMPAX LABS INC | 50MG/25ML (2MG/ML) | AP | ["AP"] | 2007-08-09 | Aug 9, 2007 | No | No | No | RX | IMPAX LABORATORIES INC | 3a7894d69d4a68a010d96cda56bfb42c19376d11ca05ad09191896c0c432fefd |
| 9917 | A | 065331 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | IMPAX LABS INC | 200MG/100ML (2MG/ML) | AP | ["AP"] | 2007-08-09 | Aug 9, 2007 | No | No | No | RX | IMPAX LABORATORIES INC | 21c2eb7a9046d95bb45fd90acb26e7bb514c0f9de9e32bb6861f7db1ebeacbd1 |
| 9918 | A | 065371 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | MYLAN INSTITUTIONAL | 50MG/25ML (2MG/ML) | | [] | 2007-11-28 | Nov 28, 2007 | No | No | No | DISCN | MYLAN INSTITUTIONAL LLC | 5098840c1b9e55be624b09c83dcc0c029dd70196ddeca8c682314e8fbee2c6dc |
| 9919 | A | 065371 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | MYLAN INSTITUTIONAL | 200MG/100ML (2MG/ML) | | [] | 2007-11-28 | Nov 28, 2007 | No | No | No | DISCN | MYLAN INSTITUTIONAL LLC | d828b1dcf6c0dc041b9e05e52e3d918c87ca64e5fae7b28b7b88c01bc117f1b5 |
| 9920 | A | 091599 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | MYLAN LABS LTD | 50MG/25ML (2MG/ML) | | [] | 2012-03-12 | Mar 12, 2012 | No | No | No | DISCN | MYLAN LABORATORIES LTD | 7f772e86fb7763cd11870658590578ddbe1474fd9ddf96e825e89c8736fb1801 |
| 9921 | A | 091599 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | MYLAN LABS LTD | 200MG/100ML (2MG/ML) | | [] | 2012-03-12 | Mar 12, 2012 | No | No | No | DISCN | MYLAN LABORATORIES LTD | 5bb91d07a9ccd393b08cd01204739a7ef258e6250a00f7c848b26a9d81497a3b |
| 9922 | A | 065289 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | WEST-WARD PHARMS INT | 50MG/25ML (2MG/ML) | AP | ["AP"] | 2007-06-27 | Jun 27, 2007 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | eee51a00eed86bbe90f7326bda58daff6476952acacc32cfc526542f301dc013 |
| 9923 | A | 065289 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | WEST-WARD PHARMS INT | 200MG/100ML (2MG/ML) | AP | ["AP"] | 2007-06-27 | Jun 27, 2007 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 3b43dc3d1ffd5f4486ad1494f2d50102355e46c16ba6ce152cb593e9ff78155f |
| 9924 | A | 090266 | 001 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | ZENNOVA | 50MG/25ML (2MG/ML) | | [] | 2011-04-15 | Apr 15, 2011 | No | No | No | DISCN | ZENNOVA PHARMACEUTICALS CHENGDU CO LTD | 65193e500399c10f68735440eb157ef6433f622ce586cf0cf9d20b0e1571dff6 |
| 9925 | A | 090266 | 002 | EPIRUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPIRUBICIN HYDROCHLORIDE | ZENNOVA | 200MG/100ML (2MG/ML) | | [] | 2011-04-15 | Apr 15, 2011 | No | No | No | DISCN | ZENNOVA PHARMACEUTICALS CHENGDU CO LTD | 0e451aaa58cac88601bf420b08b349c08857f73015a32c14f95517e01a2026d8 |
| 9926 | A | 210473 | 001 | EPOPROSTENOL SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPOPROSTENOL SODIUM | SUN PHARM | EQ 0.5MG BASE/VIAL | AP2 | ["AP2"] | 2021-01-15 | Jan 15, 2021 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | d5718b59a30c232504fefde3b815cb966a765475c1f1da4658d18bf4b9c0ec86 |
| 9927 | A | 210473 | 002 | EPOPROSTENOL SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPOPROSTENOL SODIUM | SUN PHARM | EQ 1.5MG BASE/VIAL | AP2 | ["AP2"] | 2021-01-15 | Jan 15, 2021 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | ea023d9026937dae99ef23be4984c58e7b86fb869502e665839e493794061bbe |
| 9928 | A | 078396 | 001 | EPOPROSTENOL SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPOPROSTENOL SODIUM | TEVA PHARMS USA | EQ 0.5MG BASE/VIAL | AP1 | ["AP1"] | 2008-04-23 | Apr 23, 2008 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 9960fe3ee852092078f470bd36915be4b4ef0d7e3b6bdc263f34cc0edde8a3ab |
| 9929 | A | 078396 | 002 | EPOPROSTENOL SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPOPROSTENOL SODIUM | TEVA PHARMS USA | EQ 1.5MG BASE/VIAL | AP1 | ["AP1"] | 2008-04-23 | Apr 23, 2008 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 610535b5326d86e0475fd5d261018d2a3737fb7ae37d898eb11fb1e2d5d8f6f9 |
| 9930 | A | 205557 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | ACCORD HLTHCARE | 2MG/ML | AP | ["AP"] | 2017-11-06 | Nov 6, 2017 | No | No | No | RX | ACCORD HEALTHCARE INC | 4e9d753bb41f882ed4a02cf3062db14fdeabf6cae27c09bc896a5289677f66d4 |
| 9931 | A | 205557 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | ACCORD HLTHCARE | 75MG/100ML | AP | ["AP"] | 2017-11-06 | Nov 6, 2017 | No | No | No | RX | ACCORD HEALTHCARE INC | 6a784b429fcd64aae31e8522a231aff79daf436de56ad7f3d243cee207e42197 |
| 9932 | A | 204589 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | AKORN | 2MG/ML | AP | ["AP"] | 2017-04-18 | Apr 18, 2017 | No | No | No | RX | AKORN OPERATING CO LLC | 4dff8f648bf5ace683f0a332d1ccf7a2b1b0c35d9de15d1a98b4f93788705cb7 |
| 9933 | A | 204589 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | AKORN | 75MG/100ML | AP | ["AP"] | 2017-04-18 | Apr 18, 2017 | No | No | No | RX | AKORN OPERATING CO LLC | 5a14f14f5ebd00691c567a181d562550fa90019b8780797f3b1284d36fdc4ac5 |
| 9934 | A | 205581 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | AMNEAL PHARMS | 2MG/ML | | [] | 2016-12-08 | Dec 8, 2016 | No | No | No | DISCN | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 4f5a77d4e20d1001b02ca518ff57f9c8b27554208ecbd76c4026d6f80f5140d3 |
| 9935 | A | 205581 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | AMNEAL PHARMS | 75MG/100ML | | [] | 2016-12-08 | Dec 8, 2016 | No | No | No | DISCN | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | e45a62a3a6bd2f85cd884d9e29e1bf4aab54df7288645297e6bced809a5232f7 |
| 9936 | A | 206127 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | AUROBINDO PHARMA LTD | 2MG/ML | AP | ["AP"] | 2015-12-08 | Dec 8, 2015 | No | No | No | RX | AUROBINDO PHARMA LTD | 8edfdd0614e27f47989e0e4096cbb75ac6bfd431ecd0898702f16ffb1b357200 |
| 9937 | A | 206127 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | AUROBINDO PHARMA LTD | 75MG/100ML | AP | ["AP"] | 2015-12-08 | Dec 8, 2015 | No | No | No | RX | AUROBINDO PHARMA LTD | 683d98f110aa14cdf7f9a12d146dd0fea932eb604852cbc4dda1f080da353b46 |
| 9938 | A | 208554 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | BAXTER HLTHCARE CORP | 2MG/ML | AP | ["AP"] | 2018-11-23 | Nov 23, 2018 | No | No | No | RX | BAXTER HEALTHCARE CORP | 27a1e6b52ffbed290fcb2ecc0c1ec0c830f86049de7158a18fdac0efc2debef2 |
| 9939 | A | 208554 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | BAXTER HLTHCARE CORP | 75MG/100ML | AP | ["AP"] | 2018-11-23 | Nov 23, 2018 | No | No | No | RX | BAXTER HEALTHCARE CORP | d32aaa4a744959d1bb35e65eaf59665306d9df9b3b58840b5141d908bae1957f |
| 9940 | A | 209864 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | HAINAN POLY PHARM | 2MG/ML | AP | ["AP"] | 2019-01-25 | Jan 25, 2019 | No | No | No | RX | HAINAN POLY PHARMACEUTICAL CO LTD | 4f3c99a7a5fe923aacc458a54e095446d0cad739fb509361816f3d83f82a544a |
| 9941 | A | 209864 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | HAINAN POLY PHARM | 75MG/100ML | AP | ["AP"] | 2019-01-25 | Jan 25, 2019 | No | No | No | RX | HAINAN POLY PHARMACEUTICAL CO LTD | 51aa9b1f78afb67385b2c759cdf6f5461c2a02e3b1d2cf5dceb27921bc25c680 |
| 9942 | A | 207864 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | HYBIO | 2MG/ML | | [] | 2020-03-20 | Mar 20, 2020 | No | No | No | DISCN | HYBIO PHARMACEUTICAL CO LTD | f12d13374f65ebf80df51ddf2bb80c40810a1c3053b43864f33bf87c8922e4a4 |
| 9943 | A | 207864 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | HYBIO | 75MG/100ML | | [] | 2020-03-20 | Mar 20, 2020 | No | No | No | DISCN | HYBIO PHARMACEUTICAL CO LTD | e3cd9192592b60785a42b687ce19d9b3433932fde8dc5b2b0dc654b0c7ecbdb7 |
| 9944 | A | 203258 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | MYLAN LABS LTD | 2MG/ML | AP | ["AP"] | 2018-07-20 | Jul 20, 2018 | No | No | No | RX | MYLAN LABORATORIES LTD | 07076781a780465dbe44a9dabf9f28bf6e5d42017263f4ce63f8df84e598f1ad |
| 9945 | A | 203258 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | MYLAN LABS LTD | 75MG/100ML | AP | ["AP"] | 2018-07-20 | Jul 20, 2018 | No | No | No | RX | MYLAN LABORATORIES LTD | 5ed768d99d7c883535849e57643888960221c2e1df524636f1755be2126be5e5 |
| 9946 | A | 204693 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | SAGENT PHARMS INC | 2MG/ML | AP | ["AP"] | 2018-03-07 | Mar 7, 2018 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | ce9699631db5713b0737aceb12a69fe99c4f11f92657195c13e97607d5bcca09 |
| 9947 | A | 204693 | 002 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | SAGENT PHARMS INC | 75MG/100ML | AP | ["AP"] | 2018-03-07 | Mar 7, 2018 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | e10ccebab8efe45060b3ba7559b1929af7ec5922ac0d720a40efff2c34d6714f |
| 9948 | A | 090854 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | TEVA PHARMS USA | 2MG/ML | AP | ["AP"] | 2015-06-12 | Jun 12, 2015 | No | No | No | RX | TEVA PHARMACEUTICALS USA | f3ea8268d2df2fec84b8a7dd537534e3ad209e5482ae37c5bd1978d12cf379aa |
| 9949 | A | 091555 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | TEVA PHARMS USA | 75MG/100ML | | [] | 2015-06-05 | Jun 5, 2015 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA | f61f29e4022d0c76d614ac938c24590e3e36be6ba865a6279b4b01dbfb32d8e0 |
| 9950 | A | 204361 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | USV | 2MG/ML | | [] | 2019-03-14 | Mar 14, 2019 | No | No | No | DISCN | USV PRIVATE LTD | 65508a5784076d0e385c0831e260e999c9109f0cd851c40a26d85e84b45672fa |
| 9951 | A | 204362 | 001 | EPTIFIBATIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | EPTIFIBATIDE | USV | 2MG/ML | | [] | 2019-03-11 | Mar 11, 2019 | No | No | No | DISCN | USV PRIVATE LTD | 487ca2926a9c262fa1443e02e0528438455e8b8ed9c370b129f8b928798535be |